Global Blood Plasma Derivatives Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Blood Plasma Derivatives market size was valued at US$ 30220 million in 2023. With growing demand in downstream market, the Blood Plasma Derivatives is forecast to a readjusted size of US$ 45180 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Blood Plasma Derivatives market. Blood Plasma Derivatives are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Blood Plasma Derivatives. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Blood Plasma Derivatives market.
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Blood Plasma Derivatives market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Blood Plasma Derivatives market. It may include historical data, market segmentation by Type (e.g., Albumin, Factor VIII), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Blood Plasma Derivatives market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Blood Plasma Derivatives market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Blood Plasma Derivatives industry. This include advancements in Blood Plasma Derivatives technology, Blood Plasma Derivatives new entrants, Blood Plasma Derivatives new investment, and other innovations that are shaping the future of Blood Plasma Derivatives.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Blood Plasma Derivatives market. It includes factors influencing customer ' purchasing decisions, preferences for Blood Plasma Derivatives product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Blood Plasma Derivatives market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Blood Plasma Derivatives market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Blood Plasma Derivatives market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Blood Plasma Derivatives industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Blood Plasma Derivatives market.
Market Segmentation:
Blood Plasma Derivatives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Blood Plasma Derivatives market size was valued at US$ 30220 million in 2023. With growing demand in downstream market, the Blood Plasma Derivatives is forecast to a readjusted size of US$ 45180 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Blood Plasma Derivatives market. Blood Plasma Derivatives are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Blood Plasma Derivatives. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Blood Plasma Derivatives market.
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Blood Plasma Derivatives market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Blood Plasma Derivatives market. It may include historical data, market segmentation by Type (e.g., Albumin, Factor VIII), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Blood Plasma Derivatives market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Blood Plasma Derivatives market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Blood Plasma Derivatives industry. This include advancements in Blood Plasma Derivatives technology, Blood Plasma Derivatives new entrants, Blood Plasma Derivatives new investment, and other innovations that are shaping the future of Blood Plasma Derivatives.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Blood Plasma Derivatives market. It includes factors influencing customer ' purchasing decisions, preferences for Blood Plasma Derivatives product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Blood Plasma Derivatives market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Blood Plasma Derivatives market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Blood Plasma Derivatives market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Blood Plasma Derivatives industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Blood Plasma Derivatives market.
Market Segmentation:
Blood Plasma Derivatives market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Albumin
- Factor VIII
- Factor IX
- Immunoglobulin
- Hyperimmune Globulin
- Others
- Hospitals
- Clinics
- Other End Users
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Grifols
- SK Plasma
- Fusion Health Care
- Biotest AG
- Green Cross Corporation
- Baxter International
- LFB
- Octapharma AG
- CSL Limited
- Takeda
- China Biologic Products
- Kedrion Biopharma
- BDI Pharma
- Bayer AG
- Hualan Biological Engineering
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Plasma Derivatives Market Size 2019-2030
2.1.2 Blood Plasma Derivatives Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Blood Plasma Derivatives Segment by Type
2.2.1 Albumin
2.2.2 Factor VIII
2.2.3 Factor IX
2.2.4 Immunoglobulin
2.2.5 Hyperimmune Globulin
2.2.6 Others
2.3 Blood Plasma Derivatives Market Size by Type
2.3.1 Blood Plasma Derivatives Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
2.4 Blood Plasma Derivatives Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other End Users
2.5 Blood Plasma Derivatives Market Size by Application
2.5.1 Blood Plasma Derivatives Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
3 BLOOD PLASMA DERIVATIVES MARKET SIZE BY PLAYER
3.1 Blood Plasma Derivatives Market Size Market Share by Players
3.1.1 Global Blood Plasma Derivatives Revenue by Players (2019-2024)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2019-2024)
3.2 Global Blood Plasma Derivatives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD PLASMA DERIVATIVES BY REGIONS
4.1 Blood Plasma Derivatives Market Size by Regions (2019-2024)
4.2 Americas Blood Plasma Derivatives Market Size Growth (2019-2024)
4.3 APAC Blood Plasma Derivatives Market Size Growth (2019-2024)
4.4 Europe Blood Plasma Derivatives Market Size Growth (2019-2024)
4.5 Middle East & Africa Blood Plasma Derivatives Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Blood Plasma Derivatives Market Size by Country (2019-2024)
5.2 Americas Blood Plasma Derivatives Market Size by Type (2019-2024)
5.3 Americas Blood Plasma Derivatives Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Plasma Derivatives Market Size by Region (2019-2024)
6.2 APAC Blood Plasma Derivatives Market Size by Type (2019-2024)
6.3 APAC Blood Plasma Derivatives Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood Plasma Derivatives by Country (2019-2024)
7.2 Europe Blood Plasma Derivatives Market Size by Type (2019-2024)
7.3 Europe Blood Plasma Derivatives Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Plasma Derivatives by Region (2019-2024)
8.2 Middle East & Africa Blood Plasma Derivatives Market Size by Type (2019-2024)
8.3 Middle East & Africa Blood Plasma Derivatives Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD PLASMA DERIVATIVES MARKET FORECAST
10.1 Global Blood Plasma Derivatives Forecast by Regions (2025-2030)
10.1.1 Global Blood Plasma Derivatives Forecast by Regions (2025-2030)
10.1.2 Americas Blood Plasma Derivatives Forecast
10.1.3 APAC Blood Plasma Derivatives Forecast
10.1.4 Europe Blood Plasma Derivatives Forecast
10.1.5 Middle East & Africa Blood Plasma Derivatives Forecast
10.2 Americas Blood Plasma Derivatives Forecast by Country (2025-2030)
10.2.1 United States Blood Plasma Derivatives Market Forecast
10.2.2 Canada Blood Plasma Derivatives Market Forecast
10.2.3 Mexico Blood Plasma Derivatives Market Forecast
10.2.4 Brazil Blood Plasma Derivatives Market Forecast
10.3 APAC Blood Plasma Derivatives Forecast by Region (2025-2030)
10.3.1 China Blood Plasma Derivatives Market Forecast
10.3.2 Japan Blood Plasma Derivatives Market Forecast
10.3.3 Korea Blood Plasma Derivatives Market Forecast
10.3.4 Southeast Asia Blood Plasma Derivatives Market Forecast
10.3.5 India Blood Plasma Derivatives Market Forecast
10.3.6 Australia Blood Plasma Derivatives Market Forecast
10.4 Europe Blood Plasma Derivatives Forecast by Country (2025-2030)
10.4.1 Germany Blood Plasma Derivatives Market Forecast
10.4.2 France Blood Plasma Derivatives Market Forecast
10.4.3 UK Blood Plasma Derivatives Market Forecast
10.4.4 Italy Blood Plasma Derivatives Market Forecast
10.4.5 Russia Blood Plasma Derivatives Market Forecast
10.5 Middle East & Africa Blood Plasma Derivatives Forecast by Region (2025-2030)
10.5.1 Egypt Blood Plasma Derivatives Market Forecast
10.5.2 South Africa Blood Plasma Derivatives Market Forecast
10.5.3 Israel Blood Plasma Derivatives Market Forecast
10.5.4 Turkey Blood Plasma Derivatives Market Forecast
10.5.5 GCC Countries Blood Plasma Derivatives Market Forecast
10.6 Global Blood Plasma Derivatives Forecast by Type (2025-2030)
10.7 Global Blood Plasma Derivatives Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Grifols
11.1.1 Grifols Company Information
11.1.2 Grifols Blood Plasma Derivatives Product Offered
11.1.3 Grifols Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Grifols Main Business Overview
11.1.5 Grifols Latest Developments
11.2 SK Plasma
11.2.1 SK Plasma Company Information
11.2.2 SK Plasma Blood Plasma Derivatives Product Offered
11.2.3 SK Plasma Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 SK Plasma Main Business Overview
11.2.5 SK Plasma Latest Developments
11.3 Fusion Health Care
11.3.1 Fusion Health Care Company Information
11.3.2 Fusion Health Care Blood Plasma Derivatives Product Offered
11.3.3 Fusion Health Care Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Fusion Health Care Main Business Overview
11.3.5 Fusion Health Care Latest Developments
11.4 Biotest AG
11.4.1 Biotest AG Company Information
11.4.2 Biotest AG Blood Plasma Derivatives Product Offered
11.4.3 Biotest AG Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biotest AG Main Business Overview
11.4.5 Biotest AG Latest Developments
11.5 Green Cross Corporation
11.5.1 Green Cross Corporation Company Information
11.5.2 Green Cross Corporation Blood Plasma Derivatives Product Offered
11.5.3 Green Cross Corporation Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Green Cross Corporation Main Business Overview
11.5.5 Green Cross Corporation Latest Developments
11.6 Baxter International
11.6.1 Baxter International Company Information
11.6.2 Baxter International Blood Plasma Derivatives Product Offered
11.6.3 Baxter International Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Baxter International Main Business Overview
11.6.5 Baxter International Latest Developments
11.7 LFB
11.7.1 LFB Company Information
11.7.2 LFB Blood Plasma Derivatives Product Offered
11.7.3 LFB Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 LFB Main Business Overview
11.7.5 LFB Latest Developments
11.8 Octapharma AG
11.8.1 Octapharma AG Company Information
11.8.2 Octapharma AG Blood Plasma Derivatives Product Offered
11.8.3 Octapharma AG Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Octapharma AG Main Business Overview
11.8.5 Octapharma AG Latest Developments
11.9 CSL Limited
11.9.1 CSL Limited Company Information
11.9.2 CSL Limited Blood Plasma Derivatives Product Offered
11.9.3 CSL Limited Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CSL Limited Main Business Overview
11.9.5 CSL Limited Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Blood Plasma Derivatives Product Offered
11.10.3 Takeda Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 China Biologic Products
11.11.1 China Biologic Products Company Information
11.11.2 China Biologic Products Blood Plasma Derivatives Product Offered
11.11.3 China Biologic Products Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 China Biologic Products Main Business Overview
11.11.5 China Biologic Products Latest Developments
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Company Information
11.12.2 Kedrion Biopharma Blood Plasma Derivatives Product Offered
11.12.3 Kedrion Biopharma Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Kedrion Biopharma Main Business Overview
11.12.5 Kedrion Biopharma Latest Developments
11.13 BDI Pharma
11.13.1 BDI Pharma Company Information
11.13.2 BDI Pharma Blood Plasma Derivatives Product Offered
11.13.3 BDI Pharma Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BDI Pharma Main Business Overview
11.13.5 BDI Pharma Latest Developments
11.14 Bayer AG
11.14.1 Bayer AG Company Information
11.14.2 Bayer AG Blood Plasma Derivatives Product Offered
11.14.3 Bayer AG Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bayer AG Main Business Overview
11.14.5 Bayer AG Latest Developments
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Company Information
11.15.2 Hualan Biological Engineering Blood Plasma Derivatives Product Offered
11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Hualan Biological Engineering Main Business Overview
11.15.5 Hualan Biological Engineering Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Plasma Derivatives Market Size 2019-2030
2.1.2 Blood Plasma Derivatives Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Blood Plasma Derivatives Segment by Type
2.2.1 Albumin
2.2.2 Factor VIII
2.2.3 Factor IX
2.2.4 Immunoglobulin
2.2.5 Hyperimmune Globulin
2.2.6 Others
2.3 Blood Plasma Derivatives Market Size by Type
2.3.1 Blood Plasma Derivatives Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
2.4 Blood Plasma Derivatives Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other End Users
2.5 Blood Plasma Derivatives Market Size by Application
2.5.1 Blood Plasma Derivatives Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
3 BLOOD PLASMA DERIVATIVES MARKET SIZE BY PLAYER
3.1 Blood Plasma Derivatives Market Size Market Share by Players
3.1.1 Global Blood Plasma Derivatives Revenue by Players (2019-2024)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2019-2024)
3.2 Global Blood Plasma Derivatives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD PLASMA DERIVATIVES BY REGIONS
4.1 Blood Plasma Derivatives Market Size by Regions (2019-2024)
4.2 Americas Blood Plasma Derivatives Market Size Growth (2019-2024)
4.3 APAC Blood Plasma Derivatives Market Size Growth (2019-2024)
4.4 Europe Blood Plasma Derivatives Market Size Growth (2019-2024)
4.5 Middle East & Africa Blood Plasma Derivatives Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Blood Plasma Derivatives Market Size by Country (2019-2024)
5.2 Americas Blood Plasma Derivatives Market Size by Type (2019-2024)
5.3 Americas Blood Plasma Derivatives Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Plasma Derivatives Market Size by Region (2019-2024)
6.2 APAC Blood Plasma Derivatives Market Size by Type (2019-2024)
6.3 APAC Blood Plasma Derivatives Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood Plasma Derivatives by Country (2019-2024)
7.2 Europe Blood Plasma Derivatives Market Size by Type (2019-2024)
7.3 Europe Blood Plasma Derivatives Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Plasma Derivatives by Region (2019-2024)
8.2 Middle East & Africa Blood Plasma Derivatives Market Size by Type (2019-2024)
8.3 Middle East & Africa Blood Plasma Derivatives Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD PLASMA DERIVATIVES MARKET FORECAST
10.1 Global Blood Plasma Derivatives Forecast by Regions (2025-2030)
10.1.1 Global Blood Plasma Derivatives Forecast by Regions (2025-2030)
10.1.2 Americas Blood Plasma Derivatives Forecast
10.1.3 APAC Blood Plasma Derivatives Forecast
10.1.4 Europe Blood Plasma Derivatives Forecast
10.1.5 Middle East & Africa Blood Plasma Derivatives Forecast
10.2 Americas Blood Plasma Derivatives Forecast by Country (2025-2030)
10.2.1 United States Blood Plasma Derivatives Market Forecast
10.2.2 Canada Blood Plasma Derivatives Market Forecast
10.2.3 Mexico Blood Plasma Derivatives Market Forecast
10.2.4 Brazil Blood Plasma Derivatives Market Forecast
10.3 APAC Blood Plasma Derivatives Forecast by Region (2025-2030)
10.3.1 China Blood Plasma Derivatives Market Forecast
10.3.2 Japan Blood Plasma Derivatives Market Forecast
10.3.3 Korea Blood Plasma Derivatives Market Forecast
10.3.4 Southeast Asia Blood Plasma Derivatives Market Forecast
10.3.5 India Blood Plasma Derivatives Market Forecast
10.3.6 Australia Blood Plasma Derivatives Market Forecast
10.4 Europe Blood Plasma Derivatives Forecast by Country (2025-2030)
10.4.1 Germany Blood Plasma Derivatives Market Forecast
10.4.2 France Blood Plasma Derivatives Market Forecast
10.4.3 UK Blood Plasma Derivatives Market Forecast
10.4.4 Italy Blood Plasma Derivatives Market Forecast
10.4.5 Russia Blood Plasma Derivatives Market Forecast
10.5 Middle East & Africa Blood Plasma Derivatives Forecast by Region (2025-2030)
10.5.1 Egypt Blood Plasma Derivatives Market Forecast
10.5.2 South Africa Blood Plasma Derivatives Market Forecast
10.5.3 Israel Blood Plasma Derivatives Market Forecast
10.5.4 Turkey Blood Plasma Derivatives Market Forecast
10.5.5 GCC Countries Blood Plasma Derivatives Market Forecast
10.6 Global Blood Plasma Derivatives Forecast by Type (2025-2030)
10.7 Global Blood Plasma Derivatives Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Grifols
11.1.1 Grifols Company Information
11.1.2 Grifols Blood Plasma Derivatives Product Offered
11.1.3 Grifols Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Grifols Main Business Overview
11.1.5 Grifols Latest Developments
11.2 SK Plasma
11.2.1 SK Plasma Company Information
11.2.2 SK Plasma Blood Plasma Derivatives Product Offered
11.2.3 SK Plasma Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 SK Plasma Main Business Overview
11.2.5 SK Plasma Latest Developments
11.3 Fusion Health Care
11.3.1 Fusion Health Care Company Information
11.3.2 Fusion Health Care Blood Plasma Derivatives Product Offered
11.3.3 Fusion Health Care Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Fusion Health Care Main Business Overview
11.3.5 Fusion Health Care Latest Developments
11.4 Biotest AG
11.4.1 Biotest AG Company Information
11.4.2 Biotest AG Blood Plasma Derivatives Product Offered
11.4.3 Biotest AG Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biotest AG Main Business Overview
11.4.5 Biotest AG Latest Developments
11.5 Green Cross Corporation
11.5.1 Green Cross Corporation Company Information
11.5.2 Green Cross Corporation Blood Plasma Derivatives Product Offered
11.5.3 Green Cross Corporation Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Green Cross Corporation Main Business Overview
11.5.5 Green Cross Corporation Latest Developments
11.6 Baxter International
11.6.1 Baxter International Company Information
11.6.2 Baxter International Blood Plasma Derivatives Product Offered
11.6.3 Baxter International Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Baxter International Main Business Overview
11.6.5 Baxter International Latest Developments
11.7 LFB
11.7.1 LFB Company Information
11.7.2 LFB Blood Plasma Derivatives Product Offered
11.7.3 LFB Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 LFB Main Business Overview
11.7.5 LFB Latest Developments
11.8 Octapharma AG
11.8.1 Octapharma AG Company Information
11.8.2 Octapharma AG Blood Plasma Derivatives Product Offered
11.8.3 Octapharma AG Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Octapharma AG Main Business Overview
11.8.5 Octapharma AG Latest Developments
11.9 CSL Limited
11.9.1 CSL Limited Company Information
11.9.2 CSL Limited Blood Plasma Derivatives Product Offered
11.9.3 CSL Limited Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CSL Limited Main Business Overview
11.9.5 CSL Limited Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Blood Plasma Derivatives Product Offered
11.10.3 Takeda Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 China Biologic Products
11.11.1 China Biologic Products Company Information
11.11.2 China Biologic Products Blood Plasma Derivatives Product Offered
11.11.3 China Biologic Products Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 China Biologic Products Main Business Overview
11.11.5 China Biologic Products Latest Developments
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Company Information
11.12.2 Kedrion Biopharma Blood Plasma Derivatives Product Offered
11.12.3 Kedrion Biopharma Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Kedrion Biopharma Main Business Overview
11.12.5 Kedrion Biopharma Latest Developments
11.13 BDI Pharma
11.13.1 BDI Pharma Company Information
11.13.2 BDI Pharma Blood Plasma Derivatives Product Offered
11.13.3 BDI Pharma Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 BDI Pharma Main Business Overview
11.13.5 BDI Pharma Latest Developments
11.14 Bayer AG
11.14.1 Bayer AG Company Information
11.14.2 Bayer AG Blood Plasma Derivatives Product Offered
11.14.3 Bayer AG Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bayer AG Main Business Overview
11.14.5 Bayer AG Latest Developments
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Company Information
11.15.2 Hualan Biological Engineering Blood Plasma Derivatives Product Offered
11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Hualan Biological Engineering Main Business Overview
11.15.5 Hualan Biological Engineering Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
.
Table 1. Blood Plasma Derivatives Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Factor VIII
Table 4. Major Players of Factor IX
Table 5. Major Players of Immunoglobulin
Table 6. Major Players of Hyperimmune Globulin
Table 7. Major Players of Others
Table 8. Blood Plasma Derivatives Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 11. Blood Plasma Derivatives Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 14. Global Blood Plasma Derivatives Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Blood Plasma Derivatives Revenue Market Share by Player (2019-2024)
Table 16. Blood Plasma Derivatives Key Players Head office and Products Offered
Table 17. Blood Plasma Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Blood Plasma Derivatives Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Blood Plasma Derivatives Market Size Market Share by Regions (2019-2024)
Table 22. Global Blood Plasma Derivatives Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Blood Plasma Derivatives Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Blood Plasma Derivatives Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Blood Plasma Derivatives Market Size Market Share by Country (2019-2024)
Table 26. Americas Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 28. Americas Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 30. APAC Blood Plasma Derivatives Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Blood Plasma Derivatives Market Size Market Share by Region (2019-2024)
Table 32. APAC Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 34. APAC Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 36. Europe Blood Plasma Derivatives Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Blood Plasma Derivatives Market Size Market Share by Country (2019-2024)
Table 38. Europe Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 40. Europe Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Blood Plasma Derivatives Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Blood Plasma Derivatives
Table 49. Key Market Challenges & Risks of Blood Plasma Derivatives
Table 50. Key Industry Trends of Blood Plasma Derivatives
Table 51. Global Blood Plasma Derivatives Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Blood Plasma Derivatives Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Blood Plasma Derivatives Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Blood Plasma Derivatives Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Grifols Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 56. Grifols Blood Plasma Derivatives Product Offered
Table 57. Grifols Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Grifols Main Business
Table 59. Grifols Latest Developments
Table 60. SK Plasma Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 61. SK Plasma Blood Plasma Derivatives Product Offered
Table 62. SK Plasma Main Business
Table 63. SK Plasma Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. SK Plasma Latest Developments
Table 65. Fusion Health Care Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 66. Fusion Health Care Blood Plasma Derivatives Product Offered
Table 67. Fusion Health Care Main Business
Table 68. Fusion Health Care Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Fusion Health Care Latest Developments
Table 70. Biotest AG Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 71. Biotest AG Blood Plasma Derivatives Product Offered
Table 72. Biotest AG Main Business
Table 73. Biotest AG Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Biotest AG Latest Developments
Table 75. Green Cross Corporation Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 76. Green Cross Corporation Blood Plasma Derivatives Product Offered
Table 77. Green Cross Corporation Main Business
Table 78. Green Cross Corporation Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Green Cross Corporation Latest Developments
Table 80. Baxter International Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 81. Baxter International Blood Plasma Derivatives Product Offered
Table 82. Baxter International Main Business
Table 83. Baxter International Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Baxter International Latest Developments
Table 85. LFB Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 86. LFB Blood Plasma Derivatives Product Offered
Table 87. LFB Main Business
Table 88. LFB Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. LFB Latest Developments
Table 90. Octapharma AG Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 91. Octapharma AG Blood Plasma Derivatives Product Offered
Table 92. Octapharma AG Main Business
Table 93. Octapharma AG Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Octapharma AG Latest Developments
Table 95. CSL Limited Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 96. CSL Limited Blood Plasma Derivatives Product Offered
Table 97. CSL Limited Main Business
Table 98. CSL Limited Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. CSL Limited Latest Developments
Table 100. Takeda Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 101. Takeda Blood Plasma Derivatives Product Offered
Table 102. Takeda Main Business
Table 103. Takeda Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Takeda Latest Developments
Table 105. China Biologic Products Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 106. China Biologic Products Blood Plasma Derivatives Product Offered
Table 107. China Biologic Products Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. China Biologic Products Main Business
Table 109. China Biologic Products Latest Developments
Table 110. Kedrion Biopharma Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 111. Kedrion Biopharma Blood Plasma Derivatives Product Offered
Table 112. Kedrion Biopharma Main Business
Table 113. Kedrion Biopharma Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Kedrion Biopharma Latest Developments
Table 115. BDI Pharma Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 116. BDI Pharma Blood Plasma Derivatives Product Offered
Table 117. BDI Pharma Main Business
Table 118. BDI Pharma Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. BDI Pharma Latest Developments
Table 120. Bayer AG Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 121. Bayer AG Blood Plasma Derivatives Product Offered
Table 122. Bayer AG Main Business
Table 123. Bayer AG Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Bayer AG Latest Developments
Table 125. Hualan Biological Engineering Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 126. Hualan Biological Engineering Blood Plasma Derivatives Product Offered
Table 127. Hualan Biological Engineering Main Business
Table 128. Hualan Biological Engineering Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Hualan Biological Engineering Latest Developments
.
Table 1. Blood Plasma Derivatives Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Factor VIII
Table 4. Major Players of Factor IX
Table 5. Major Players of Immunoglobulin
Table 6. Major Players of Hyperimmune Globulin
Table 7. Major Players of Others
Table 8. Blood Plasma Derivatives Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 11. Blood Plasma Derivatives Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 14. Global Blood Plasma Derivatives Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Blood Plasma Derivatives Revenue Market Share by Player (2019-2024)
Table 16. Blood Plasma Derivatives Key Players Head office and Products Offered
Table 17. Blood Plasma Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Blood Plasma Derivatives Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Blood Plasma Derivatives Market Size Market Share by Regions (2019-2024)
Table 22. Global Blood Plasma Derivatives Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Blood Plasma Derivatives Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Blood Plasma Derivatives Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Blood Plasma Derivatives Market Size Market Share by Country (2019-2024)
Table 26. Americas Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 28. Americas Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 30. APAC Blood Plasma Derivatives Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Blood Plasma Derivatives Market Size Market Share by Region (2019-2024)
Table 32. APAC Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 34. APAC Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 36. Europe Blood Plasma Derivatives Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Blood Plasma Derivatives Market Size Market Share by Country (2019-2024)
Table 38. Europe Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 40. Europe Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Blood Plasma Derivatives Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Blood Plasma Derivatives Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Blood Plasma Derivatives Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Blood Plasma Derivatives
Table 49. Key Market Challenges & Risks of Blood Plasma Derivatives
Table 50. Key Industry Trends of Blood Plasma Derivatives
Table 51. Global Blood Plasma Derivatives Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Blood Plasma Derivatives Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Blood Plasma Derivatives Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Blood Plasma Derivatives Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Grifols Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 56. Grifols Blood Plasma Derivatives Product Offered
Table 57. Grifols Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Grifols Main Business
Table 59. Grifols Latest Developments
Table 60. SK Plasma Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 61. SK Plasma Blood Plasma Derivatives Product Offered
Table 62. SK Plasma Main Business
Table 63. SK Plasma Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. SK Plasma Latest Developments
Table 65. Fusion Health Care Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 66. Fusion Health Care Blood Plasma Derivatives Product Offered
Table 67. Fusion Health Care Main Business
Table 68. Fusion Health Care Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Fusion Health Care Latest Developments
Table 70. Biotest AG Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 71. Biotest AG Blood Plasma Derivatives Product Offered
Table 72. Biotest AG Main Business
Table 73. Biotest AG Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Biotest AG Latest Developments
Table 75. Green Cross Corporation Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 76. Green Cross Corporation Blood Plasma Derivatives Product Offered
Table 77. Green Cross Corporation Main Business
Table 78. Green Cross Corporation Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Green Cross Corporation Latest Developments
Table 80. Baxter International Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 81. Baxter International Blood Plasma Derivatives Product Offered
Table 82. Baxter International Main Business
Table 83. Baxter International Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Baxter International Latest Developments
Table 85. LFB Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 86. LFB Blood Plasma Derivatives Product Offered
Table 87. LFB Main Business
Table 88. LFB Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. LFB Latest Developments
Table 90. Octapharma AG Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 91. Octapharma AG Blood Plasma Derivatives Product Offered
Table 92. Octapharma AG Main Business
Table 93. Octapharma AG Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Octapharma AG Latest Developments
Table 95. CSL Limited Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 96. CSL Limited Blood Plasma Derivatives Product Offered
Table 97. CSL Limited Main Business
Table 98. CSL Limited Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. CSL Limited Latest Developments
Table 100. Takeda Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 101. Takeda Blood Plasma Derivatives Product Offered
Table 102. Takeda Main Business
Table 103. Takeda Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Takeda Latest Developments
Table 105. China Biologic Products Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 106. China Biologic Products Blood Plasma Derivatives Product Offered
Table 107. China Biologic Products Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. China Biologic Products Main Business
Table 109. China Biologic Products Latest Developments
Table 110. Kedrion Biopharma Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 111. Kedrion Biopharma Blood Plasma Derivatives Product Offered
Table 112. Kedrion Biopharma Main Business
Table 113. Kedrion Biopharma Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Kedrion Biopharma Latest Developments
Table 115. BDI Pharma Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 116. BDI Pharma Blood Plasma Derivatives Product Offered
Table 117. BDI Pharma Main Business
Table 118. BDI Pharma Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. BDI Pharma Latest Developments
Table 120. Bayer AG Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 121. Bayer AG Blood Plasma Derivatives Product Offered
Table 122. Bayer AG Main Business
Table 123. Bayer AG Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Bayer AG Latest Developments
Table 125. Hualan Biological Engineering Details, Company Type, Blood Plasma Derivatives Area Served and Its Competitors
Table 126. Hualan Biological Engineering Blood Plasma Derivatives Product Offered
Table 127. Hualan Biological Engineering Main Business
Table 128. Hualan Biological Engineering Blood Plasma Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Hualan Biological Engineering Latest Developments
LIST OF FIGURES
.
Figure 1. Blood Plasma Derivatives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Plasma Derivatives Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Blood Plasma Derivatives Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Blood Plasma Derivatives Sales Market Share by Country/Region (2023)
Figure 8. Blood Plasma Derivatives Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Blood Plasma Derivatives Market Size Market Share by Type in 2023
Figure 10. Blood Plasma Derivatives in Hospitals
Figure 11. Global Blood Plasma Derivatives Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Blood Plasma Derivatives in Clinics
Figure 13. Global Blood Plasma Derivatives Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Blood Plasma Derivatives in Other End Users
Figure 15. Global Blood Plasma Derivatives Market: Other End Users (2019-2024) & ($ Millions)
Figure 16. Global Blood Plasma Derivatives Market Size Market Share by Application in 2023
Figure 17. Global Blood Plasma Derivatives Revenue Market Share by Player in 2023
Figure 18. Global Blood Plasma Derivatives Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 20. APAC Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 21. Europe Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 23. Americas Blood Plasma Derivatives Value Market Share by Country in 2023
Figure 24. United States Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Blood Plasma Derivatives Market Size Market Share by Region in 2023
Figure 29. APAC Blood Plasma Derivatives Market Size Market Share by Type in 2023
Figure 30. APAC Blood Plasma Derivatives Market Size Market Share by Application in 2023
Figure 31. China Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Blood Plasma Derivatives Market Size Market Share by Country in 2023
Figure 38. Europe Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Figure 39. Europe Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Figure 40. Germany Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 54. APAC Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 55. Europe Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 57. United States Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 58. Canada Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 61. China Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 62. Japan Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 63. Korea Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 65. India Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 66. Australia Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 67. Germany Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 68. France Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 69. UK Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 70. Italy Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 71. Russia Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 72. Spain Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 75. Israel Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 78. Global Blood Plasma Derivatives Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Blood Plasma Derivatives Market Size Market Share Forecast by Application (2025-2030)
.
Figure 1. Blood Plasma Derivatives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood Plasma Derivatives Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Blood Plasma Derivatives Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Blood Plasma Derivatives Sales Market Share by Country/Region (2023)
Figure 8. Blood Plasma Derivatives Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Blood Plasma Derivatives Market Size Market Share by Type in 2023
Figure 10. Blood Plasma Derivatives in Hospitals
Figure 11. Global Blood Plasma Derivatives Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Blood Plasma Derivatives in Clinics
Figure 13. Global Blood Plasma Derivatives Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Blood Plasma Derivatives in Other End Users
Figure 15. Global Blood Plasma Derivatives Market: Other End Users (2019-2024) & ($ Millions)
Figure 16. Global Blood Plasma Derivatives Market Size Market Share by Application in 2023
Figure 17. Global Blood Plasma Derivatives Revenue Market Share by Player in 2023
Figure 18. Global Blood Plasma Derivatives Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 20. APAC Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 21. Europe Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Blood Plasma Derivatives Market Size 2019-2024 ($ Millions)
Figure 23. Americas Blood Plasma Derivatives Value Market Share by Country in 2023
Figure 24. United States Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Blood Plasma Derivatives Market Size Market Share by Region in 2023
Figure 29. APAC Blood Plasma Derivatives Market Size Market Share by Type in 2023
Figure 30. APAC Blood Plasma Derivatives Market Size Market Share by Application in 2023
Figure 31. China Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Blood Plasma Derivatives Market Size Market Share by Country in 2023
Figure 38. Europe Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Figure 39. Europe Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Figure 40. Germany Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Blood Plasma Derivatives Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Blood Plasma Derivatives Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 54. APAC Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 55. Europe Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 57. United States Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 58. Canada Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 61. China Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 62. Japan Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 63. Korea Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 65. India Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 66. Australia Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 67. Germany Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 68. France Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 69. UK Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 70. Italy Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 71. Russia Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 72. Spain Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 75. Israel Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Blood Plasma Derivatives Market Size 2025-2030 ($ Millions)
Figure 78. Global Blood Plasma Derivatives Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Blood Plasma Derivatives Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Digital Mammography Machine Market Growth 2025-2031
US$ 3,660.00
August 2025
127 pages
Global Sterile Gamma-Irradiated IPA Market Growth 2024-2030
US$ 3,660.00
December 2024
91 pages
Global Tumor Embolization Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
78 pages
Global Therapeutic Wearable Medical Devices Market Growth 2024-2030
US$ 3,660.00
December 2024
106 pages
Global Colorectal Cancer Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
104 pages
